Similar Items: Preclinical evaluation of [F]fluoroethylresorufin as PET tracer for cerebral amyloid angiopathy
- Preclinical PET characterization of [Ga]Ga-EMP-100 for non-invasive assessment of c-Met in NSCLC
- Dual-time-point [F]FDG-PET/CT as a prognostic biomarker in patients with pleural mesothelioma undergoing immunotherapy
- Reconstruction matters: influence of EARL standards and BSREM in [F]FET PET for distinguishing glioma progression from treatment-related changes
- Toward reproducible metabolic tumor volume quantification in endometrial cancer: optimizing [¹⁸F]FDG PET/CT tumor segmentation methods
- Complementary roles of 68Ga-FAPI and 18 F-FDG PET/CT in evaluating IgG4-related disease: a systematic review and pooled analysis
- Impact of different PSMA PET-based eligibility criteria on outcome of [Lu]Lu-PSMA radioligand therapy using [F]rhPSMA-7/[F]rhPSMA-7.3 (Flotufolastat)